MCHI vs KURE
YTDYear to date
KURE wins+18.7 pts
Past year
KURE wins+16.7 pts
Fee
MCHI winslower fee
Yield
KURE wins+1.9 pts
AUM
MCHI51.6× more
3–1KURE wins
MCHI and KURE · year-to-date · as of Nov 3, 2026 · AUM not scored
KURE vs S&P 500
YTD$17.34 · −1.6% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return−1.6%−9.4%−0.7%+1.8%−4.8%+7.5%−42.4%−14.4%
Peer average+1.0%−8.6%−16.4%−17.0%−20.3%+21.9%−29.5%—
S&P 500 · VOO−0.5%−2.3%−2.2%+11.2%+11.8%+89.5%+77.1%+813.5%
KraneShares KURE and Vanguard VOO · total return, dividends in · as of Nov 3, 2026
KURE’s Holdings
Today6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%3692.HK3.0%000538.SZ2.6%688271.SS2.5%300015.SZ2.1%6990.HK2.0%1530.HK2.0%600436.SS2.0%002422.SZ1.8%300759.SZ1.7%1099.HK1.6%31 more
6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 3, 2026
All 25 China ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | MSCI ChinaReadDesk | 0.59% | 2.2% | −16.9% | −16.9% | $5.6B | |
| 2 | KWEB | KraneShares CSI China InternetReadDesk | 0.69% | 9.0% | −31.4% | −31.4% | $4.3B | |
| 3 | FXI | China Large-CapReadDesk | 0.73% | 2.0% | −12.6% | −12.6% | $3.8B | |
| 4 | CQQQ | China TechnologyReadDesk | 0.65% | 2.9% | −26.0% | −26.0% | $1.7B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-ReadDesk | 0.65% | 2.5% | −8.1% | −8.1% | $1.3B | |
| 6 | GXC | State Street SPDR S&P ChinaReadDesk | 0.59% | 2.4% | −15.3% | −15.3% | $421M | |
| 7 | CXSE | WisdomTree China ex-State-Owned EnterprisesReadDesk | 0.32% | 2.2% | −20.5% | −20.5% | $372M | |
| 8 | FLCH | Franklin FTSE ChinaReadDesk | 0.19% | 2.6% | −17.0% | −17.0% | $252M | |
| 9 | CNYA | MSCI China AReadDesk | 0.60% | 2.1% | −11.5% | −11.5% | $159M | |
| 10 | KURE | KraneShares MSCI All China Health CareReadDesk | 0.79% | 4.1% | +1.8% | +1.8% | $108M | |
| 11 | KBA | KraneShares Bosera MSCI China A 50 ConnectReadDesk | 0.79% | 1.7% | −8.8% | −8.8% | $105M | |
| 12 | CHIQ | Global X - MSCI China Consumer DiscretionaryReadDesk | 0.65% | 1.8% | −25.3% | −25.3% | $97.2M | |
| 13 | PGJ | Golden Dragon ChinaReadDesk | 0.70% | 2.0% | −25.3% | −25.3% | $76.2M | |
| 14 | ECNS | MSCI China Small-CapReadDesk | 0.59% | 7.4% | −20.7% | −20.7% | $56.1M | |
| 15 | CNQQ | Rayliant-ChinaAMC Transformative China TechReadDesk | 0.75% | 0.5% | −21.0% | −21.0% | $43.8M | |
| 16 | KGRN | KraneShares MSCI China Clean TechnologyReadDesk | 0.79% | 1.1% | −22.1% | −22.1% | $42.4M |
1–16 of 25Page 1 of 2
China · current AUM · as of Nov 3, 2026
KURE Payouts by Year
8YLatest payout, Dec 2025
$0.71
a share · once a year
4.1% yield
4.1% yield
8 years added up
$5.21 a share
$5.21 a share
KraneShares KURE · per-share distributions by ex-date · 2018–2025
KURE’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | iShares MSCI China ETFReadVersus | 0.59% | 2.2% | +1.1% | −16.9% | −21.5% | $5.6B | |
| 2 | KWEB | KraneShares CSI China Internet ETFReadVersus | 0.69% | 9.0% | +2.7% | −31.4% | −38.4% | $4.3B | |
| 3 | FXI | iShares China Large-Cap ETFReadVersus | 0.73% | 2.0% | +0.4% | −12.6% | −15.8% | $3.8B | |
| 4 | CQQQ | Invesco China Technology ETFReadVersus | 0.65% | 2.9% | +1.9% | −26.0% | −31.1% | $1.7B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-Shares ETFReadVersus | 0.65% | 2.5% | +0.5% | −8.1% | −7.9% | $1.3B | |
| 6 | KURE | KraneShares MSCI All China Health Care Index ETFThis fund | 0.79% | 4.1% | −1.6% | +1.8% | −4.8% | $108M |
#2 of 25 this year · #17 cheapest of 25 · sorted by assetsOpen the Thematic table →
KURE and its peer group · total return · as of Nov 3, 2026
Cards for This View
KURE’s Top 10 Holdings
Today53.0%of KURE sits in these 10
16160.HBeone Medicines8.92%
21801.HInnovent Biologics7.97%
32269.HWuxi Biologics Cayman7.28%
4603259Wuxi Apptec -A5.47%
5600276Jiangsu Hengrui Pharmaceut-A4.79%
6300760Shenzhen Mindray Bio-Medic-A4.62%
79926.HAkeso3.90%
81177.HSino Biopharmaceutical3.62%
91093.HCspc Pharmaceutical Group Lt3.39%
102359.HWuxi Apptec -H3.08%
KraneShares KURE · weight in the fund · as of Nov 3, 2026
KURE’s Holdings
Today6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%3692.HK3.0%000538.SZ2.6%688271.SS2.5%300015.SZ2.1%6990.HK2.0%1530.HK2.0%600436.SS2.0%002422.SZ1.8%300759.SZ1.7%1099.HK1.6%31 more
6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 3, 2026
KURE vs Peer Average
YTDKUREAvsBPeer average
1D−1.6%+1.0%
1M−9.4%−8.6%
3M−0.7%−16.4%
YTD+1.8%−17.0%
1Y−4.8%−20.3%
3Y+7.5%+21.9%
5Y−42.4%−29.5%
3–4Peer average wins
24 China peers · each row scaled to its leader